Toxicity spectrum of taxanes: a safety analysis from pre-marketing to post-marketing

The safety of nab-paclitaxel was beyond expectation and unusual signals of alopecia and depression of docetaxel need to be paid attention to. Results of clinical trials and FAERS indicated consistency between premarket and postmarket studies.